Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-000233
Filing Date
2025-01-07
Accepted
2025-01-07 16:04:52
Documents
1
Period of Report
2025-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3891
  Complete submission text file 0001562180-25-000233.txt   5501
Mailing Address
Business Address
ANDO GORAN (Reporting) CIK: 0001110748 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 25514869

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)